iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 3,730.00
-55.00 (-1.45%)
Apr 29, 2026, 11:48 AM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 119.66 billion as of April 28, 2026. Its market cap has increased by 7.12% in one year.
Market Cap
119.66B
Enterprise Value
81.24B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,730.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 119.66B, an increase of 25.56%. That is a compound annual growth rate of 1.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 119.66B | 16.46% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 258.32B |
| Macrogen | 185.93B |
| MedPacto | 183.71B |
| Vaxcell-Bio Therapeutics | 181.17B |
| ENCell | 176.61B |
| Amicogen | 131.18B |
| Oncocross | 107.32B |
| IMB Dx | 102.61B |